Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-042727
Filing Date
2025-03-20
Accepted
2025-03-20 16:36:40
Documents
6
Effectiveness Date
2025-03-20

Document Format Files

Seq Description Document Type Size
1 S-8 tern-s8-q125.htm S-8 150935
2 EX-5.1 tern-ex5_1.htm EX-5.1 12898
3 EX-23.1 tern-ex23_1.htm EX-23.1 4787
4 EX-FILING FEES tern-exfiling_fees.htm EX-FILING FEES 30784
5 GRAPHIC img60210087_0.jpg GRAPHIC 36009
6 GRAPHIC img60210087_1.jpg GRAPHIC 328100
  Complete submission text file 0000950170-25-042727.txt   702181
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285966 | Film No.: 25757024
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)